Coldrex MaxGrip Berry Fruit  1000 mg/10 mg/70 mg powder for oral solution  България - български - Изпълнителна агенция по лекарствата

coldrex maxgrip berry fruit  1000 mg/10 mg/70 mg powder for oral solution 

glaxosmithkline consumer healthcare, glaxosmithkline export ltd - Парацетамол, комбинации без. психолептиков - 1000 mg/10 mg/70 mg powder for oral solution 

Coldrex  tablets България - български - Изпълнителна агенция по лекарствата

coldrex  tablets

glaxosmithkline consumer healthcare, glaxosmithkline export ltd - Парацетамол, комбинации без. психолептиков - tablets

Coldrex Menthol Active 600 mg/10 mg/40 mg powder for oral solution България - български - Изпълнителна агенция по лекарствата

coldrex menthol active 600 mg/10 mg/40 mg powder for oral solution

glaxosmithkline consumer healthcare, glaxosmithkline export ltd - Парацетамол, комбинации без. психолептиков - 600 mg/10 mg/40 mg powder for oral solution

Onpattro Европейски съюз - български - EMA (European Medicines Agency)

onpattro

alnylam netherlands b.v. - patisiran натрий - Амилоидоза, Фамилна - Други лекарства в нервната система - onpattro е показан за лечение на наследствени транстиретина-посредничанного амилоидоза (hattr амилоидоза) при възрастни пациенти с 1 етап 2 етап полиневропатия.

Kymriah Европейски съюз - български - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - Други антинеопластични средства - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Yescarta Европейски съюз - български - EMA (European Medicines Agency)

yescarta

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - Антинеопластични средства - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

PRACETAM 200 mg/g powder for use in drinking water for pigs 200 mg/g България - български - БАБХ (Българска агенция по безопасност на храните)

pracetam 200 mg/g powder for use in drinking water for pigs 200 mg/g

Сева Анимал Хелт България ЕООД - Парацетамол - прах за прилагане във вода за пиене - 200 mg/g - прасета

PRACETAM 200 mg/ml solution for use in drinking water for pigs 200 mg/ml България - български - БАБХ (Българска агенция по безопасност на храните)

pracetam 200 mg/ml solution for use in drinking water for pigs 200 mg/ml

Сева Анимал Хелт България ЕООД - Парацетамол - разтвор за прилагане във вода за пиене - 200 mg/ml - прасета

Tecartus Европейски съюз - български - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - Лимфом, мантел-клетка - Антинеопластични средства - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Abecma Европейски съюз - български - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - Антинеопластични средства - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.